Market Cap 2.30M
Revenue (ttm) 0.00
Net Income (ttm) -3.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,000
Avg Vol 14,408
Day's Range N/A - N/A
Shares Out 1.80M
Stochastic %K 33%
Beta 0.89
Analysts Strong Buy
Price Target $22.20

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surg...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 552 4452
Address:
2 Burlington Woods Drive, Suite 100, Burlington, United States
OfficialStocktwitsUser
OfficialStocktwitsUser May. 5 at 10:47 PM
$BBLG RSI: 51.39, MACD: 0.0219 Vol: 0.05, MA20: 1.32, MA50: 1.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SkullInferno
SkullInferno May. 1 at 11:41 PM
0 · Reply
SkullInferno
SkullInferno May. 1 at 11:38 PM
$BBLG bullish
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 3:46 AM
0 · Reply
Harold_the_Hedge
Harold_the_Hedge Apr. 18 at 4:50 PM
$BBLG wen dilution and rs
0 · Reply
terrapin22
terrapin22 Apr. 17 at 7:02 PM
$BBLG jump
0 · Reply
terrapin22
terrapin22 Apr. 10 at 5:42 PM
0 · Reply
Rampageusa
Rampageusa Apr. 8 at 12:59 PM
$ELAB & or $BBLG we will Squeeze 7.5/9.5
0 · Reply
AIBioScanner
AIBioScanner Apr. 1 at 7:11 AM
$BBLG AI-Based Findings on BBLG After running BBLG through my AI-driven quantitative framework, the stock remains in a sustained downtrend with signs of stabilization near recent lows. BBLG is trading around $1.08, below both the 20-day (~$1.20) and 50-day (~$1.33) moving averages — indicating continued weakness. Key signals: • Weak momentum after prolonged decline • MACD likely still negative • Range between ~$1.07 support and ~$1.89 resistance As shown in the chart, the stock has been trending lower with consistent lower highs, now attempting to stabilize near its bottom range. 1-Month Outlook: Base scenario: consolidation between $1.05–$1.40 Breakout above $1.40 could open a move toward $1.70–$1.90 Breakdown below $1.05 may extend downside pressure Structure remains weak and requires confirmation for any reversal. Not financial advice.
0 · Reply
WallStpolitician
WallStpolitician Mar. 22 at 4:02 AM
$BBLG That red area highlights the 5 milestones  The arrows I highlighted are my key indicators on if this becomes a +$25 stock come after the IDE -$MDT failed -the guy who sold both products joined here -so effectively they should have low cost in distribution etc -Efficient Approval Path: Clear FDA pathway - filing planned as a device/drug combination under Pre-Market Approval (PMA) should happen -Early-Pathway Stimulation: rhBMP induces a molecular cascade early in the pathway -a Major is going to just wait for them to prove that they could do the $3 billion business & buy them to tackle the $11 -15billion dollar business 🚀
1 · Reply
Latest News on BBLG
Bone Biologics summarizes key milestones achieved during 2025

2026-01-08T13:40:29.000Z - 4 months ago

Bone Biologics summarizes key milestones achieved during 2025


Bone Biologics Announces Closing of $5.0 Million Public Offering

Jun 30, 2025, 4:10 PM EDT - 11 months ago

Bone Biologics Announces Closing of $5.0 Million Public Offering


Bone Biologics Announces Pricing of $5.0 Million Public Offering

Jun 27, 2025, 9:10 AM EDT - 11 months ago

Bone Biologics Announces Pricing of $5.0 Million Public Offering


Why Is Bone Biologics Stock (BBLG) Up 100% Today?

2025-06-27T12:25:15.000Z - 11 months ago

Why Is Bone Biologics Stock (BBLG) Up 100% Today?


Bone Biologics regains compliance with Nasdaq listing

2025-06-26T20:25:38.000Z - 11 months ago

Bone Biologics regains compliance with Nasdaq listing


Bone Biologics files $35M mixed securities shelf

2025-06-24T21:05:27.000Z - 11 months ago

Bone Biologics files $35M mixed securities shelf


Bone Biologics Corp trading halted, news pending

2025-06-09T23:50:10.000Z - 1 year ago

Bone Biologics Corp trading halted, news pending


Bone Biologics announces 1-for-6 reverse stock split

2025-06-06T12:15:30.000Z - 1 year ago

Bone Biologics announces 1-for-6 reverse stock split


Bone Biologics Announces 1-for-6 Reverse Stock Split

Jun 6, 2025, 8:00 AM EDT - 1 year ago

Bone Biologics Announces 1-for-6 Reverse Stock Split


Bone Biologics reports progress with NB1 clinical program

2024-03-01T13:06:39.000Z - 2 years ago

Bone Biologics reports progress with NB1 clinical program


Bone Biologics Reports Progress With NB1 Clinical Program

Mar 1, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Reports Progress With NB1 Clinical Program


Bone Biologics Corp trading halted, news pending

2023-12-20T00:50:00.000Z - 2 years ago

Bone Biologics Corp trading halted, news pending


Bone Biologics announces 1-for-8 reverse stock split

2023-12-18T13:12:24.000Z - 2 years ago

Bone Biologics announces 1-for-8 reverse stock split


Bone Biologics Announces 1-for-8 Reverse Stock Split

Dec 18, 2023, 8:00 AM EST - 2 years ago

Bone Biologics Announces 1-for-8 Reverse Stock Split


Bone Biologics Prices $5.0 Million Underwritten Public Offering

Jun 14, 2023, 11:30 PM EDT - 3 years ago

Bone Biologics Prices $5.0 Million Underwritten Public Offering


Bone Biologics Effects 1-for-30 Reverse Stock Split

Jun 6, 2023, 1:00 PM EDT - 3 years ago

Bone Biologics Effects 1-for-30 Reverse Stock Split


Bone Biologics CEO Issues Letter to Stockholders

Oct 25, 2022, 8:00 AM EDT - 3 years ago

Bone Biologics CEO Issues Letter to Stockholders


OfficialStocktwitsUser
OfficialStocktwitsUser May. 5 at 10:47 PM
$BBLG RSI: 51.39, MACD: 0.0219 Vol: 0.05, MA20: 1.32, MA50: 1.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SkullInferno
SkullInferno May. 1 at 11:41 PM
0 · Reply
SkullInferno
SkullInferno May. 1 at 11:38 PM
$BBLG bullish
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 3:46 AM
0 · Reply
Harold_the_Hedge
Harold_the_Hedge Apr. 18 at 4:50 PM
$BBLG wen dilution and rs
0 · Reply
terrapin22
terrapin22 Apr. 17 at 7:02 PM
$BBLG jump
0 · Reply
terrapin22
terrapin22 Apr. 10 at 5:42 PM
0 · Reply
Rampageusa
Rampageusa Apr. 8 at 12:59 PM
$ELAB & or $BBLG we will Squeeze 7.5/9.5
0 · Reply
AIBioScanner
AIBioScanner Apr. 1 at 7:11 AM
$BBLG AI-Based Findings on BBLG After running BBLG through my AI-driven quantitative framework, the stock remains in a sustained downtrend with signs of stabilization near recent lows. BBLG is trading around $1.08, below both the 20-day (~$1.20) and 50-day (~$1.33) moving averages — indicating continued weakness. Key signals: • Weak momentum after prolonged decline • MACD likely still negative • Range between ~$1.07 support and ~$1.89 resistance As shown in the chart, the stock has been trending lower with consistent lower highs, now attempting to stabilize near its bottom range. 1-Month Outlook: Base scenario: consolidation between $1.05–$1.40 Breakout above $1.40 could open a move toward $1.70–$1.90 Breakdown below $1.05 may extend downside pressure Structure remains weak and requires confirmation for any reversal. Not financial advice.
0 · Reply
WallStpolitician
WallStpolitician Mar. 22 at 4:02 AM
$BBLG That red area highlights the 5 milestones  The arrows I highlighted are my key indicators on if this becomes a +$25 stock come after the IDE -$MDT failed -the guy who sold both products joined here -so effectively they should have low cost in distribution etc -Efficient Approval Path: Clear FDA pathway - filing planned as a device/drug combination under Pre-Market Approval (PMA) should happen -Early-Pathway Stimulation: rhBMP induces a molecular cascade early in the pathway -a Major is going to just wait for them to prove that they could do the $3 billion business & buy them to tackle the $11 -15billion dollar business 🚀
1 · Reply
SqueezeMagnet33
SqueezeMagnet33 Mar. 3 at 6:40 PM
$BBLG Flag and High Vol . On watch
0 · Reply
ZacksSCR
ZacksSCR Mar. 3 at 6:10 PM
$BBLG Financials Show Company in Solid Shape https://buff.ly/HZGunNX
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 3:07 AM
$BBLG Current Stock Price: $1.19
0 · Reply
ZacksSCR
ZacksSCR Feb. 25 at 4:07 PM
$BBLG Approaching Crucial Stage https://buff.ly/q9GcSlz
0 · Reply
joedoe007
joedoe007 Feb. 19 at 1:35 AM
$BBLG Bone Biologics. Ok. Well, what kind of Bones 🦴 do they do biologics in ?? Chicken bones , dinosaur bones or fish bones ?? 🦴 What are the results of the biologics performed since company inspection?? Do they accept donations of leftover bones for their research biologics work ??
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 16 at 5:31 PM
$BBLG RSI: 11.08, MACD: -0.1167 Vol: 0.19, MA20: 1.56, MA50: 1.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
shakemystock
shakemystock Feb. 6 at 2:47 PM
$BBLG bad management dead stock
0 · Reply
Harold_the_Hedge
Harold_the_Hedge Jan. 20 at 7:22 PM
$BBLG haha 4 years ago this stock was $5000.. imagine you bought some shares for the long term and its $1.74 right now. Only in Amurica
0 · Reply
WadehN21
WadehN21 Jan. 17 at 1:49 AM
$BBLG Tuesday..... rocket
0 · Reply
WadehN21
WadehN21 Jan. 16 at 6:31 PM
$BBLG I'm sensing news imminent
0 · Reply
VB_TrappinStockz
VB_TrappinStockz Jan. 16 at 5:19 PM
$BBLG bubbling up 👀
0 · Reply